<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03327844</url>
  </required_header>
  <id_info>
    <org_study_id>DSRB 2015/00612</org_study_id>
    <nct_id>NCT03327844</nct_id>
  </id_info>
  <brief_title>Regenerative Endodontic Therapy (RET) for the Management of Immature Non-vital Permanent Teeth in Children</brief_title>
  <official_title>Regenerative Endodontic Therapy (RET) Using Antibiotic Pastes or Calcium Hydroxide Disinfection for the Management of Immature Non-vital Permanent Teeth in Children: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Health System, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National University, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Promotion Board, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National University Health System, Singapore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy of Antibiotic pastes or Calcium hydroxide disinfection on&#xD;
      healing of periapical pathology and continued root development of infected non-vital immature&#xD;
      permanent teeth in children.&#xD;
&#xD;
      In the test group regenerative endodontic therapy (RET) is performed with antibiotics as the&#xD;
      disinfecting agent, in the control group RET is performed with Calcium Hydroxide as the&#xD;
      disinfecting agent.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">July 31, 2021</completion_date>
  <primary_completion_date type="Actual">July 31, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resolution periapical radiolucency (Clinical evaluation)</measure>
    <time_frame>18 months (reviews are at periodicity of 3 months)</time_frame>
    <description>Clinical evaluation: Presence/Absence of clinical signs of pain and soft tissue pathology (e.g. abscess, sinus tract etc.)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resolution periapical radiolucency (Radiographic evaluation)</measure>
    <time_frame>18 months (reviews are at periodicity of 3 months)</time_frame>
    <description>Size of periapical lesion will be graded using Periapical Index (PAI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Continued root development (Radiographic evaluation)</measure>
    <time_frame>18 months (reviews are at periodicity of 3 months)</time_frame>
    <description>Quantitative outcomes of lengths and thickness will be measured in millimeters (mm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discolouration of tooth</measure>
    <time_frame>18 months (reviews are at periodicity of 3 months)</time_frame>
    <description>Changes in tooth colour will be measured through assessment of photographs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcomes (Perceived oral health-related quality of life (OHRQL))</measure>
    <time_frame>18 months (reviews are at periodicity of 3 months)</time_frame>
    <description>Oral health related quality of life will be evaluated using the validated questionnaire Child-Oral Impacts on daily performances (C-OIDP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcomes (Quantitative pain rating)</measure>
    <time_frame>18 months (reviews are at periodicity of 3 months)</time_frame>
    <description>Quantitative pain rating will be done using Faces Pain scale for children 12 years and below; and Numeric Rating scale (NRS) for children 13 years and above.&#xD;
Faces Pain Scale (range: 0-10); higher scores indicate worse pain&#xD;
Numeric Rating scale (range: 0-10; 0 - no pain, 1-3 - mild pain, 4-6 - moderate pain, 7-10 - severe pain); higher scores indicate worse pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Infected Immature Permanent Teeth</condition>
  <arm_group>
    <arm_group_label>RET using bi-Antibiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interventions: Bi-antibiotics (Ciprofloxacin and Metronidazole) placed into the root canal during first treatment stage (disinfection stage)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RET using non-setting Calcium Hydroxide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interventions: non-setting calcium hydroxide placed into the root canal during first treatment stage (disinfection stage)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RET using antibiotics (Ciprofloxacin and Metronidazole)</intervention_name>
    <description>RET using antibiotics Ciprofloxacin and Metronidazole. First Treatment Visit: Local analgesic, tooth isolation, access, pulp extirpation and root canal irrigation with 1.5% sodium hypochlorite. Canal drying using paper points. Delivery of mixture of Bi antibiotic paste (Ciprofloxacin and Metronidazole with sterile water). Tooth access sealed with temporary dressing. Second Treatment Visit: Tooth analgesia using plain local analgesics without vasoconstriction, isolation and re-access as described above. Irrigation of root canal system using sodium hypochlorite followed by paper point drying. Initiation of bleeding through insertion of a sterile k-file at a length of 2-3 mm beyond the working length into the periapical tissues. Access sealed using resorbable plug, Biodentine, followed by composite resin.</description>
    <arm_group_label>RET using bi-Antibiotics</arm_group_label>
    <other_name>Bi-Antibiotics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RET using non-setting Calcium Hydroxide</intervention_name>
    <description>First Treatment Visit: Local analgesic, Tooth isolation, access, pulp extirpation and root canal irrigation with 1.5% sodium hypochlorite. Canal negotiation, canal drying using paper points. Delivery of the non-setting Calcium Hydroxide. Tooth access sealed with temporary dressing. Second Treatment Visit: Tooth analgesia using plain local analgesics without vasoconstrictor, isolation and re-access as described above. Irrigation of root canal system using sodium hypochlorite followed by paper point drying. Initiation of bleeding through insertion of a sterile k-file at a length of 2-3 mm beyond the working length into the periapical tissues. Access sealed using resorbable plug, Biodentine, followed by composite resin.</description>
    <arm_group_label>RET using non-setting Calcium Hydroxide</arm_group_label>
    <other_name>Calcium hydroxide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients aged 6-16 years of age&#xD;
&#xD;
          2. Patients who are fit and healthy or with American Society of Anesthesiologists (ASA) 1&#xD;
             or ASA 2 medical conditions&#xD;
&#xD;
          3. Patients with cooperation level that would allow treatment under local analgesia,&#xD;
             application of rubber dam isolation and taking of intraoral radiographs.&#xD;
&#xD;
          4. Patients with permanent premolars that have incomplete root formation with an open&#xD;
             apex of greater than 1mm width as observed radiographically and of single root canal&#xD;
             morphology (22)&#xD;
&#xD;
          5. Patients with single rooted immature permanent premolars having one of the following&#xD;
             pulpal and periapical diagnosis:&#xD;
&#xD;
             a. Pulpal i. Necrotic pulp ii. Symptomatic and inflamed pulp not expected to heal.&#xD;
             During attempted Cvek or cervical pulpotomy procedures, if the pulpal bleeding does&#xD;
             not stop with direct pressure within 5 minutes, pulpectomy will be carried out and the&#xD;
             patient will be recruited for RET procedures.&#xD;
&#xD;
             b. Periapical i. Symptomatic apical periodontitis (with or without a radiographic&#xD;
             apical lesion) ii. Asymptomatic apical periodontitis (with a radiographic apical&#xD;
             lesion) iii. Acute apical abscess iv. Chronic apical abscess Teeth will be deemed&#xD;
             non-vital if either are non-responsive to sensibility tests (i.e. Electric Pulp test&#xD;
             and cold tests), and/or present with signs and symptoms of non-vitality (e.g. swelling&#xD;
             and abscess).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients aged &gt; 16 years of age.&#xD;
&#xD;
          2. Patient with known allergies to Ciprofloxacin (or any fluoroquinolones class of&#xD;
             antibiotics) or metronidazole antibiotics.&#xD;
&#xD;
          3. Patients with medical conditions and/or receiving medications that would affect:&#xD;
&#xD;
               1. Their body's ability to heal e.g. Diabetes; or&#xD;
&#xD;
               2. Their ability to clot efficiently, e.g. Haemophilia&#xD;
&#xD;
          4. Patients with risk of developing infective endocarditis or immune compromised&#xD;
             patients.&#xD;
&#xD;
          5. Patients with non-vital permanent premolars where root development is already deemed&#xD;
             to be completed (i.e. foramen size of 0-1.0mm diameter as determined&#xD;
             radiographically).&#xD;
&#xD;
          6. Impacted or horizontally tilted teeth.&#xD;
&#xD;
          7. Concurrent signs of irreversible pathological root resorption determined&#xD;
             radiographically, e.g replacement or internal root resorption, which could otherwise&#xD;
             affect the prognosis of the tooth.&#xD;
&#xD;
          8. Uncooperative patients, or those unable to cope with treatment under local&#xD;
             anaesthesia, rubber dam isolation and taking of intraoral radiographs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huei Jinn Tong</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School Dental Service, Health Promotion Board</name>
      <address>
        <city>Singapore</city>
        <zip>168937</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 5, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2017</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National University Health System, Singapore</investigator_affiliation>
    <investigator_full_name>Tong Huei Jinn</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>Regenerative Endodontic Therapy</keyword>
  <keyword>Infected immature permanent teeth</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 21, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT03327844/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 17, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT03327844/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

